Sonoma Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $4,015 | $3,754 | $3,564 | $3,579 |
Gross Profit | 1,464 | 1,528 | 1,270 | 1,361 |
EBITDA | -1,095 | -625 | -998 | -815 |
EBIT | -1,131 | -656 | -1,031 | -850 |
Net Income | -1,241 | -776 | -928 | -610 |
Net Change In Cash | 4,015 | 3,754 | 3,564 | 3,579 |
Free Cash Flow | -2,121 | -142 | 563 | 328 |
Cash | 3,605 | 5,374 | 5,236 | 4,078 |
Basic Shares | 1,641 | 1,241 | 1,464 | 1,034 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $14,288 | $12,735 | $13,272 | $12,628 |
Gross Profit | 5,465 | 4,745 | 4,477 | 3,993 |
EBITDA | -3,572 | -4,525 | -4,445 | -5,701 |
EBIT | -3,710 | -4,701 | -4,570 | -5,887 |
Net Income | -3,457 | -4,835 | -5,151 | -5,086 |
Net Change In Cash | 14,288 | 12,735 | 13,272 | 12,628 |
Free Cash Flow | -168 | -2,415 | -6,421 | -4,385 |
Cash | 5,374 | 3,128 | 3,820 | 7,396 |
Basic Shares | 1,241 | 909 | 339 | 265 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.76 |
2025-03-31 | -$0.48 |
2024-12-31 | -$0.63 |
2024-09-30 | -$0.59 |
